Swinburne University of Technology

Professor Andrew Scholey

Andrew is Director of the Centre for Human Psychopharmacology at Swinburne University, Melbourne. He is a leading international researcher into the neurocognitive effects of nutritional interventions, recreational drugs, supplements and food components. Andrew has published around 200 peer-reviewed journal articles and has attracted over $18 million in research funding. He was lead investigator in a series of studies into the human biobehavioural effects of nutritional interventions, focusing on potential neurocognition-enhancing and anti-stress/anxiolytic properties (including first-into-human neurocognitive assessment of GinsengSage, curcumin and Lemon balm amongst others). His current research focuses on neuroimaging and biomarker techniques to better understand the mechanisms of cognitive enhancement. Andrew works closely with industry which allows rapid translation of research into evidence-based end-user health benefits.

» Find out more

Associate Professor Andrew Pipingas

Andrew is a cognitive neuroscientist and Head of Neurocognitive Ageing Research at Swinburne University’s Centre for Human Psychopharmacology. His undergraduate training was in biophysics and instrumental science. His research covers the application of cognitive and neuroimaging methodologies in the study of neurocognition and brain ageing in both cognitively healthy and cognitively impaired individuals. He has been at the forefront of developing age-sensitive computerised cognitive assessments that have been used extensively to study both cognitive ageing as well as the effects of interventions for healthy brain function. Andrew is leading projects related to healthy brain ageing including nutritional, nutraceutical and lifestyle interventions.

» Find out more